Oxford University has seen ‘right sort of immune response’ in potential COVID-19 vaccine trial

A volunteer receives a COVID-19 test vaccine injection developed at the University of Oxford in Britain, at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, South Africa. (File/AP)
Short Url
Updated 01 July 2020

Oxford University has seen ‘right sort of immune response’ in potential COVID-19 vaccine trial

  • Gilbert said she couldn’t give a timeline for when the vaccine might be ready as it depends on the results of the trial

LONDON: A leading scientist behind the University of Oxford’s potential COVID-19 vaccine said on Wednesday the team has seen the right sort of immune response in trials, which have entered the Phase III clinical stage.
Speaking at a parliamentary hearing, Sarah Gilbert, professor of vaccinology at the university, said the trial has enrolled 8,000 volunteers for the Phase III of its trial into the vaccine, AZD1222, which was licensed to AstraZeneca.
She said she couldn’t give a timeline for when the vaccine might be ready as it depends on the results of the trial.


Turkey's coronavirus death toll hits record for seventh day in a row

Updated 29 November 2020

Turkey's coronavirus death toll hits record for seventh day in a row

ISTANBUL: Turkey's daily COVID-19 death toll hit a record high for a seventh consecutive day on Sunday, with 185 fatalities in the last 24 hours, data from the Health Ministry showed.
The number of new cases of coronavirus infections, including asymptomatic ones, fell slightly to 29,281. For four months, Turkey only reported symptomatic cases, but since Wednesday it has reported all cases.
The total number of deaths since the start of the pandemic in March stood at 13,558.